Clinical Trial Update: A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU) [Phase 2]

View source ↗

Summary

Phase 2 PERU trial evaluating UFT/Leucovorin with radiotherapy with or without cetuximab after induction gemcitabine plus capecitabine in locally advanced pancr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cetuximab (cetuximab)
• Gemcitabine (Gemcitabine)
• Leucovorin (folinic acid)
• UFT (uracil-tegafur) (uracil-tegafur)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED